Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review
Tsubasa Takizawa(Keio University), Paolo Martelletti(Unitelma Sapienza University), Shunsuke Uno(Keio University), David García‐Azorín(Universidad de Valladolid), Jin Nakahara(Keio University Hospital), Keiko Ihara(Keio University), Narumi Watanabe(Keio University Hospital), Noboru Imai(Shizuoka Red Cross Hospital), Satoko Hori(Keio University), Seiya Ohtani(Keio University)
Cited by 8
Related Papers
Noninvasive vagus nerve stimulation as acute therapy for migraine
|Neurology|2018|246
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Long COVID headache
|The Journal of Headache and Pain|2022|158
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107